{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "AMRX",
    "data": {
        "bs": [
            {
                "label": "Current portion of long-term debt, net",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 30523000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -349000
            },
            {
                "label": "Total Amneal Pharmaceuticals, Inc. stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 391125000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 512241000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 512241000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 3888968000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 121408000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 121408000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1389678000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 602893000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 602893000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 666799000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 538309000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 538309000
            },
            {
                "label": "Non-controlling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 16282000
            },
            {
                "label": "Redeemable non-controlling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 16420000
            },
            {
                "label": "Redeemable non-controlling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 16420000
            },
            {
                "label": "Long-term debt, net",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 2672661000
            },
            {
                "label": "Note payable - related party",
                "concept": "NotesPayableRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 38443000
            },
            {
                "label": "Stockholders' accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -278353000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 3888968000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 1209818000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 1209818000
            },
            {
                "label": "Related party receivables",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 1175000
            },
            {
                "label": "Related party receivables",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 1175000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 210477000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 210477000
            },
            {
                "label": "Related party payables - long term",
                "concept": "DueToAffiliateNoncurrent",
                "unit": "usd",
                "value": 10371000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 500911000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 32866000
            },
            {
                "label": "Related party payables - short term",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 15960000
            },
            {
                "label": "Related party payables - short term",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 15960000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 63943000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 63943000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 602043000
            },
            {
                "label": "Total long-term liabilities",
                "concept": "LiabilitiesNoncurrent",
                "unit": "usd",
                "value": 2863098000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 6068000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 6068000
            },
            {
                "label": "Preferred stock, shares issued (in shares)",
                "concept": "PreferredStockSharesIssued",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 407407000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 407407000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 539734000
            },
            {
                "label": "Commitments and contingencies (Notes 5 and 13)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.01 par value, 2,000 shares authorized, none issued at both March\u00a031, 2022 and December\u00a031, 2021",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "cf": [
            {
                "label": "Related party receivables",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 8065000
            },
            {
                "label": "Deposits for future acquisition of property, plant, and equipment",
                "concept": "amrx:PaymentsToAcquirePropertyPlantAndEquipmentDeposits",
                "unit": "usd",
                "value": 1888000
            },
            {
                "label": "Tax distributions to non-controlling interests",
                "concept": "amrx:TaxDistributionToNoncontrollingInterestFinancingActivities",
                "unit": "usd",
                "value": 3164000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 25549000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 27289000
            },
            {
                "label": "Tax distributions to non-controlling interests",
                "concept": "amrx:TaxDistributionToNonControllingInterest",
                "unit": "usd",
                "value": 3284000
            },
            {
                "label": "Net (decrease) increase in cash, cash equivalents, and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -40194000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 111000
            },
            {
                "label": "Net cash used in financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -61570000
            },
            {
                "label": "Effect of foreign exchange rate on cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -1572000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -124268000
            },
            {
                "label": "Accounts payable, accrued expenses and other liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -48777000
            },
            {
                "label": "Other operating charges and credits, net",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -1155000
            },
            {
                "label": "Payments of principal on financing lease - related party",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 10793000
            },
            {
                "label": "Cash paid for income taxes, net",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 4387000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Prepaid expenses, other current assets and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 4423000
            },
            {
                "label": "Amortization of debt issuance costs and discount",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 2195000
            },
            {
                "label": "Inventory provision",
                "concept": "InventoryWriteDown",
                "unit": "usd",
                "value": 3578000
            },
            {
                "label": "Payments of deferred consideration for acquisitions - related party",
                "concept": "amrx:PaymentOfDeferredConsiderationForAcquisitionRelatedParty",
                "unit": "usd",
                "value": 43998000
            },
            {
                "label": "Acquisition of business",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 84714000
            },
            {
                "label": "Employee payroll tax withholding on restricted stock unit vesting",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 3001000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -97395000
            },
            {
                "label": "Unrealized foreign currency loss (gain)",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -3140000
            },
            {
                "label": "Acquisition of redeemable non-controlling interest",
                "concept": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": 1722000
            },
            {
                "label": "Net cash provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 120343000
            },
            {
                "label": "Repayment of related party note",
                "concept": "RepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Related party payables",
                "concept": "IncreaseDecreaseInDueToRelatedParties",
                "unit": "usd",
                "value": 5132000
            },
            {
                "label": "Payments of principal on debt, financing leases and other",
                "concept": "amrx:RepaymentsOfLongTermDebtAndFinancingLeaseObligations",
                "unit": "usd",
                "value": 9796000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "amrx:DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 57815000
            },
            {
                "label": "Contingent consideration for acquisition",
                "concept": "amrx:NoncashOrPartNoncashAcquisitionContingentConsiderationForAcquisition",
                "unit": "usd",
                "value": 8796000
            }
        ],
        "ic": [
            {
                "label": "Foreign exchange (loss) gain, net",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": -2013000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 174571000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 174571000
            },
            {
                "label": "(Loss) income before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -9921000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 2122000
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 149892000
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 149892000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -2156000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -2156000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -2156000
            },
            {
                "label": "Restructuring and other charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 731000
            },
            {
                "label": "Restructuring and other charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 731000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "(Benefit from) provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -3461000
            },
            {
                "label": "(Benefit from) provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -3500000.0
            },
            {
                "label": "Accretion of redeemable non-controlling interest",
                "concept": "TemporaryEquityAccretionToRedemptionValueAdjustment",
                "unit": "usd",
                "value": 438000
            },
            {
                "label": "Accretion of redeemable non-controlling interest",
                "concept": "TemporaryEquityAccretionToRedemptionValueAdjustment",
                "unit": "usd",
                "value": 438000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 98665000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 98665000
            },
            {
                "label": "Credit related to legal matters, net",
                "concept": "GainLossRelatedToLitigationSettlement",
                "unit": "usd",
                "value": 2326000
            },
            {
                "label": "Credit related to legal matters, net",
                "concept": "GainLossRelatedToLitigationSettlement",
                "unit": "usd",
                "value": 2326000
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 323062000
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 323062000
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 149892000
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 149892000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -33226000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc. before accretion of redeemable non-controlling interest",
                "concept": "amrx:NetIncomeLossAttributableToParentBeforeAccretionOfRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": -1718000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc. before accretion of redeemable non-controlling interest",
                "concept": "amrx:NetIncomeLossAttributableToParentBeforeAccretionOfRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": -1718000
            },
            {
                "label": "Basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Less: Net loss (income) attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -4742000
            },
            {
                "label": "Less: Net loss (income) attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -4742000
            },
            {
                "label": "Intellectual property legal development expenses",
                "concept": "RoyaltyExpense",
                "unit": "usd",
                "value": 764000
            },
            {
                "label": "Intellectual property legal development expenses",
                "concept": "RoyaltyExpense",
                "unit": "usd",
                "value": 764000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": -33335000
            },
            {
                "label": "Acquisition, transaction-related and integration expenses",
                "concept": "amrx:BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense",
                "unit": "usd",
                "value": 434000
            },
            {
                "label": "Acquisition, transaction-related and integration expenses",
                "concept": "amrx:BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense",
                "unit": "usd",
                "value": 434000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 52798000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 52798000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 497633000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 497633000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 497633000
            },
            {
                "label": "Operating income",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 23305000
            },
            {
                "label": "Operating income",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 23305000
            },
            {
                "label": "Unrealized gain on cash flow hedge, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
                "unit": "usd",
                "value": 53624000
            },
            {
                "label": "Unrealized gain on cash flow hedge, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
                "unit": "usd",
                "value": 53624000
            },
            {
                "label": "Less: Net loss (income) attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -4742000
            },
            {
                "label": "Less: Net loss (income) attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -4742000
            },
            {
                "label": "Other comprehensive income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 24590000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6460000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc. before accretion of redeemable non-controlling interest",
                "concept": "amrx:NetIncomeLossAttributableToParentBeforeAccretionOfRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": -1718000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc. before accretion of redeemable non-controlling interest",
                "concept": "amrx:NetIncomeLossAttributableToParentBeforeAccretionOfRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": -1718000
            },
            {
                "label": "Accretion of redeemable non-controlling interest",
                "concept": "TemporaryEquityAccretionToRedemptionValueAdjustment",
                "unit": "usd",
                "value": 438000
            },
            {
                "label": "Accretion of redeemable non-controlling interest",
                "concept": "TemporaryEquityAccretionToRedemptionValueAdjustment",
                "unit": "usd",
                "value": 438000
            },
            {
                "label": "Comprehensive income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 22434000
            },
            {
                "label": "Less: Other comprehensive income attributable to non-controlling interests",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 24955000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -2156000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -2156000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -2156000
            },
            {
                "label": "Foreign currency translation adjustments arising during the period",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -4079000
            },
            {
                "label": "Foreign currency translation adjustments arising during the period",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -4079000
            }
        ]
    }
}